Literature DB >> 22113079

A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression.

Gengming Huang1, Cornelis J Elferink.   

Abstract

The aryl hydrocarbon receptor (AhR) is a mediator of xenobiotic toxicity, best recognized for conveying the deleterious effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. The AhR functions as a ligand-activated transcription factor that binds to a canonical xenobiotic response element (XRE) in association with the heterodimerization partner, the AhR nuclear translocator (Arnt) protein. However, within the repertoire of AhR target genes identified in recent years, many lack a clearly defined XRE highlighting the growing realization that AhR-mediated gene expression seems to involve additional mechanisms distinct from the well characterized process involving the XRE. The present study characterized a novel nonconsensus XRE (NC-XRE) in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene that recruits a novel protein-DNA complex responsible for TCDD-inducible expression. DNA binding studies and reporter assays identified key residues in the NC-XRE necessary for protein-DNA binding and function, respectively. Functional studies with AhR expression constructs confirm that TCDD-inducibility is AhR-dependent and requires direct AhR-DNA binding to the NC-XRE. Chromatin immunoprecipitation and RNA interference studies reveal that the Arnt protein is not a component of the NC-XRE-bound AhR complex, suggesting that in contrast to the XRE, AhR-dependent gene expression mediated through the NC-XRE may involve a new DNA binding partner.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113079      PMCID: PMC3286297          DOI: 10.1124/mol.111.075952

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  44 in total

Review 1.  The PAS superfamily: sensors of environmental and developmental signals.

Authors:  Y Z Gu; J B Hogenesch; C A Bradfield
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 2.  The plasminogen activator system: biology and regulation.

Authors:  J P Irigoyen; P Muñoz-Cánoves; L Montero; M Koziczak; Y Nagamine
Journal:  Cell Mol Life Sci       Date:  1999-10-01       Impact factor: 9.261

3.  Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest.

Authors:  A Puga; S J Barnes; T P Dalton; C y Chang; E S Knudsen; M A Maier
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  The transcriptional signature of dioxin in human hepatoma HepG2 cells.

Authors:  A Puga; A Maier; M Medvedovic
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

5.  Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest.

Authors:  Gengming Huang; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2004-10-18       Impact factor: 4.436

6.  Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor.

Authors:  C Weiss; S K Kolluri; F Kiefer; M Göttlicher
Journal:  Exp Cell Res       Date:  1996-07-10       Impact factor: 3.905

7.  Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells.

Authors:  Y Q Chen; M Su; R R Walia; Q Hao; J W Covington; D E Vaughan
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

8.  Neuronal Promoter Analysis by in Vitro Transcription Using Nuclear Extracts from Rat Brain

Authors: 
Journal:  Methods       Date:  1996-12       Impact factor: 3.608

9.  RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.

Authors:  Christoph F A Vogel; Eric Sciullo; Wen Li; Pat Wong; Gwendal Lazennec; Fumio Matsumura
Journal:  Mol Endocrinol       Date:  2007-09-06

Review 10.  Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

Authors:  Michelle K V Durand; Julie S Bødker; Anni Christensen; Daniel M Dupont; Martin Hansen; Jan K Jensen; Signe Kjelgaard; Lisa Mathiasen; Katrine E Pedersen; Sune Skeldal; Troels Wind; Peter A Andreasen
Journal:  Thromb Haemost       Date:  2004-03       Impact factor: 5.249

View more
  55 in total

1.  Comparisons of differential gene expression elicited by TCDD, PCB126, βNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL/6 mouse liver.

Authors:  Rance Nault; Agnes L Forgacs; Edward Dere; Timothy R Zacharewski
Journal:  Toxicol Lett       Date:  2013-08-29       Impact factor: 4.372

2.  Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.

Authors:  Danica E DeGroot; Ai Hayashi; Michael S Denison
Journal:  Arch Biochem Biophys       Date:  2013-11-04       Impact factor: 4.013

3.  Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities.

Authors:  Un-Ho Jin; Syng-Ook Lee; Gautham Sridharan; Kyongbum Lee; Laurie A Davidson; Arul Jayaraman; Robert S Chapkin; Robert Alaniz; Stephen Safe
Journal:  Mol Pharmacol       Date:  2014-02-21       Impact factor: 4.436

4.  Comparison of TCDD-elicited genome-wide hepatic gene expression in Sprague-Dawley rats and C57BL/6 mice.

Authors:  Rance Nault; Suntae Kim; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

5.  Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.

Authors:  Un-Ho Jin; Sang-Bae Kim; Stephen Safe
Journal:  Chem Res Toxicol       Date:  2015-04-09       Impact factor: 3.739

6.  Canonical and non-canonical aryl hydrocarbon receptor signaling pathways.

Authors:  Eric J Wright; Karen Pereira De Castro; Aditya D Joshi; Cornelis J Elferink
Journal:  Curr Opin Toxicol       Date:  2017-01-18

7.  Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK.

Authors:  Un-Ho Jin; Keshav Karki; Sang-Bae Kim; Stephen Safe
Journal:  Biochem Biophys Res Commun       Date:  2018-06-27       Impact factor: 3.575

8.  Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Treated Mice Demonstrates NRF2-Independent PKM2 Induction.

Authors:  Rance Nault; Claire M Doskey; Kelly A Fader; Cheryl E Rockwell; Tim Zacharewski
Journal:  Mol Pharmacol       Date:  2018-05-11       Impact factor: 4.436

9.  Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.

Authors:  Daniel P Jackson; Hui Li; Kristen A Mitchell; Aditya D Joshi; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2014-01-15       Impact factor: 4.436

10.  Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.

Authors:  Rance Nault; Kelly A Fader; Dustin A Ammendolia; Peter Dornbos; Dave Potter; Bonnie Sharratt; Kazuyoshi Kumagai; Jack R Harkema; Sophia Y Lunt; Jason Matthews; Tim Zacharewski
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.